193

Chapter-12

Bibliography

194

Abbas Pardakhty , Jaleh Varshosaz , Abdolhossein Rouholamini (2007). In vitro study

of polyoxyethylene alkyl ether niosomes for delivery of insulin, International Journal

of Pharmaceutics, 328,130–141.

Abdallah Makhlof, Yuichi Tozuka, Hirofumi Takeuchi (2011). Design and evaluation

of novel pH-sensitive chitosan nanoparticles for oral insulin delivery, European

Journal of Pharmaceutical Sciences, 38,117-125.

Abu Bakar Ruzilawati, Mohd Suhaimi Abd. Wahab

, Ahmad Imran (2007). Method

development and validation of Repaglinide in human plasma by HPLC and its

application in pharmacokinetic studies, Journal of Pharmaceutical and Biomedical

Analysis ,23, 1831–1835.

Aggarwal BB, Shishodia S (2009). Suppression of the nuclear factor-kappaB

activation pathway absorption of insulin in rats from mucoadhesive chitosan-coated

liposomes. Pharm. Res, 13, 896–901.

Ahmed Besheer , Kristy M. Wood , Nicholas A. Peppas , Karsten Mäder (2006).

Loading and mobility of spin-labeled insulin in physiologically responsive

complexation hydrogels intended for oral administration, Journal of Controlled

Release, 111, 73–80.

195

Akbar Bayat, Bagher Larijani, Shahin Ahmadian (2008), Preparation and

characterization of insulin nanoparticles using chitosan and its quaternized

derivatives, Nanomedicine: Nanotechnology, Biology, and Medicine, 4,115–120.

Amani Elsayed , Mayyas Al Remawi , Nidal Qinna , Asim Farouk (2009).

Formulation and characterization of an oily-based system for oral delivery of insulin,

European Journal of Pharmaceutics and Biopharmaceutics, 73, 269–279.

Amit Kumar, Sitanshu S. Lahiri , Harpal Singh (2006). Development of PEGDMA:

MAA based hydrogel microparticles for oral insulin delivery, International Journal of

Pharmaceutics, 323,117–124.

Amnon C. Sintov , Haim V. Levy , Shafir Botner (2010). Systemic delivery of insulin

via the nasal route using a new microemulsion system:In vitro and in vivo studies,

Journal of Controlled Release, 148, 168–176.

Amnon C. Sintov , Roy Brandys-Sitton (2006). Facilitated skin penetration of

lidocaine: Combination of a short-term iontophoresis and microemulsion formulation,

International Journal of Pharmaceutics, 316, 58–67.

Amnon C. Sintov , Uri Wormser (2007). Topical iodine facilitates transdermal

delivery of insulin, Journal of Controlled Release, 118,185–188

196

Anja Graf, Thomas Rades, Sarah M. Hook (2009). Oral insulin delivery using

nanoparticles based on microemulsions with different structure-types: Optimisation

and in vivo evaluation, European journal of pharmaceutical sciences, 37,53–61.

Anna Radomska-Soukharev (2007). Stability of lipid excipients in solid lipid

nanoparticles, Advanced Drug Delivery Reviews, 59, 411–418.

Anto Shering M, Kannan C, Sabari Kumar K, Sathish Kumar (2011). Formulation of

5-fluorouracil Loaded Chitosan Nanoparticles by Emulsion Droplet Coalescence

Method for Cancer Therapy, International Journal of Pharmaceutical & Biological

Archives, 2,926-931.

Avadi M R, Saadat P, Rafiee-Tehrani M, Junginger H E (2008). Preparation,

characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC)

and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both

the ionotropic gelation and polyelectrolyte complexation methods, International

Journal of Pharmaceutics, 355,299–306.

Bae ,Ah YC, Choi JK, Choi YK, Ki HM (2010). A novel transdermal patch

incorporating meloxicam: in vitro and in vivo characterization, International Journal

of Pharmaceutics. 29,12-19.

Banerjee T, Singh AK, Sharma RK (2006). Labeling efficiency and biodistribution of

based on a skin diffusion model. Pharmaceutical Research,11, 377–383.

197

Bastos-González G. Wenz UF, Schaefer CM, Lehr (2010). Nanoparticles made from

novel starch derivatives for transdermal drug delivery, Journal of Controlled Release,

141, 85–92.

Bruno Sarmento , Domingos Ferreira , Francisco Veiga (2006). Characterization of

insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through

DSC and FTIR studies, Carbohydrate Polymers, 66, 1–7.

Bruno Sarmento, Susana Martins, Domingos Ferreira, Eliana B Souto (2007). Oral

insulin delivery by means of solid lipid Nanoparticles, International Journal of

Nanomedicine, 2, 743-749.

Camile B. Woitiski, Ronald J. Neufeld, Francisco Veiga, Rui A. Carvalho (2010).

Pharmacological effect of orally delivered insulin facilitated by multilayered stable

nanoparticles, European Journal of Pharmaceutical Sciences, 41,556–563.

Carey Munsick, Robert Murray, Tom Dziubla, Anthony M (2007).Quantitation of

Humalog Insulin by UV spectrophotometric methods, Journal of Diabetes Science

and Technology,3, 603-607.

Caruther , Wickline SA, Lanza G M (2007). Nanotechnological applications in

medicine, Current Opin Biotechnology, 18, 26–30.

198

Cevc G (2003). Transdermal drug delivery of insulin with ultradeformable carriers.

Clin Pharmacokinetic, 42, 461–474.

Chander parkash dora, shailendra kumar singh, sanjeev kumar (2010). development

and characterization of nanoparticles of glibenclamide by solvent displacement

method, acta poloniae pharmaceutica n drug research, 67, 283-290,

Changguang Wang, Zhirong Zhong, Zhirong Zhang (2007). Solid lipid nanoparticles

loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles:

Preparation and characterization, International Journal of Pharmaceutics, 340, 153–

162.

Charlotte A. Ihlo, Karin Bak Aksglæde, Torben Laursen (2009). Serum Insulin Aspart

Concentrations Following High-Dose Insulin Aspart Administered Directly into the

Duodenum of Healthy Subjects: An Open-Labeled, Single-Blinded, and Uncontrolled

Exploratory Trial, Journal of Diabetes Science Technology, 3, 1183–1191.

Christiane Damgé, Philippe Maincent, Nathalie Ubrich (2007). Oral delivery of

insulin associated to polymeric nanoparticles in diabetic rats, Journal of Controlled

Release, 117, 163–170.

Chunbai He, Liming Cui, Cui Tang, Chunhua Yin (2009). Drug permeability and

mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin

delivery, Biomaterials, 30, 5691–5700.

199

Corinne Yoong , Thomas A. Robertson H. Peter Soyer, Michael S. Roberts (2011).

Nanoparticles and microparticles for skin drug delivery, Advanced Drug Delivery

Reviews, 232, 182–197.

Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C (2002). Nanocapsule

technology: a review. Crit. Rev. Ther. Drug Carrier System, 19, 99–134.

Dhana Lekshmi UM, Poovi G, Kishore N, Reddy PN (2010). In vitro characterization

and invivo toxicity study of Repaglinide loaded poly (methyl methacrylate)

nanoparticles, International Journal of Pharmaceutics, 30, 194-203.

Dongfei Liu, Sunmin Jiang, Hong Shen, Shan Qin, Juanjuan Liu (2011). Diclofenac

sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation

method,journal of Nanoparticle Research,13, 2375-238.

Dongsheng Mou, Huabing Chen, Danrong Du, Chengwen Mao (2008). Hydrogel-

thickened nanoemulsion system for topical delivery of lipophilic drugs, International

Journal of Pharmaceutics, 353, 270–276.

Driton Vllasaliu, Ruth Exposito-Harrisb, Angeles Heras, Snow Stolnik (2010). Tight

junction modulation by chitosan nanoparticles: Comparison with chitosan solution,

International Journal of Pharmaceutics, 400, 183–193.

200

Eliziane Nitz de Carvalho, Nestor Antônio Schmidt de Carvalho (2003). Experimental

model of induction of diabetes mellitus in rats, Acta Cirurgica Brasileira, 18, 71-81.

Emmert-Buck MR, Bonner RF, Smith PD (2000). Laser capture microdissection.

Science endothelial cells. Journal Pharmacy Pharmacology, 52:1301–1317.

Fan,Wang, Fan, Ma (2006). Preparation of insulin nanoparticles and their

encapsulation with biodegradable polyelectrolyte via the layer-by-layer adsorption,

International Journal of Pharmaceutics, 324, 158–167.

Florence AT, Hussain N (2001). Transcytosis of nanoparticle and dendrimer delivery

systems: evolving vistas. Advance Drug Delivery Review, 50, S69–S89.

Frank J, Griffin, Evelyn Spittle, Christie R. Rodgers (2005). Immunoglobulin G1

Enzyme-Linked Immunosorbent Assay for Diagnosis of Johne’s Disease in Red Deer,

Clinical Diagnosis Laboraty Immunology,12, 1401–1409.

Frank Stracke, C, Barbara Weiss, Claus-M. Lehr, Karsten König (2006). Multiphoton

microscopy for the investigation of dermal penetration of nanoparticle-borne drugs,

Journal of Investigative Dermatology advance online publication, 18, 1-39.

Fude Cui, Kai Shi , Liqiang Zhang , Anjin Tao (2006). Biodegradable nanoparticles

loaded with insulin–phospholipid complex for oral delivery: Preparation, in vitro

characterization and in vivo evaluation, Journal of Controlled Release, 114, 242–250

.

201

Gary Adams , NanWang,Yuxin Cui (2005) Future alternative therapies in a quest to

halt aberrations in diabetes mellitus, Biomedicine & Pharmacotherapy, 59, 296–301.

Gautam Kumar, Ban Leong Sng, Surya Kuma (2004). Correlation of capillary and

venous blood glucometry with laboratory determination, Prehospital Emergency Care,

8, 378–383.

Geys J, Coenegrachts L, Vercammen J (2006). In vitro study of the pulmonary

translocati.on of nanoparticles: A preliminary study. Toxicological Letter, 160, 218–

226.

Gill, Davies, Pringle IA, Hyde SC (2004). The development of gene therapy for

diseases of the lung, CMLS, Cell. Mol. Life Sciences, 61, 355–368.

Gopinath, Naidu RAS (2011). Pharmaceutical Preformulation Studies – Current

Review, International Journal of Pharmaceutical & Biological Archives, 2, 1391-

1400.

Gordon, Peterson T A (2003). Four myths about transdermal drug delivery. Drug

Delivery Technology, 3, 44–50.

Guo J, Ping Q, Zhang L (2000). Transdermal delivery of insulin in mice by using

lecithin vesicles as a carrier. Drug Delivery, 7,113–116.

202

Hamid, A. Merchant, Harris, M. Shoaib, Jaweria Tazeen, Rabia Yousuf, (2006). Once

daily formulation and in vitro evaluation of cefopodoxime using hydroxy propyl

methyl cellulose –a technical note. AAPS PharmSciTech, 78, 56-63.

Hans E. Junginger, Morteza Rafiee-Tehrani, Akbar Bayat (2008). Preparation and

characterization of insulin nanoparticles using chitosan and its quaternized

derivatives, Nanomedicine: Nanotechnology, Biology, and Medicine, 4, 115–120.

Hans M L, Lowman A M (2002). Biodegradable nanoparticles for drug delivery and

targeting, Current Opinion in Solid State & Materials Science, 6, 319-327.

Hillye JF, Abrecht R.M (2001). Gastro intestinal per sorption & tissue distribution of

differently sized colloidal gold nanoparticles. Journal of Pharmaceutical Sciences, 90,

1927–1936.

Hoet M, Chen Z, Xing G, Yuan H, Chen C, Zhao F, Zhang C, Zhao Y (2007).

Ultrahigh reactivity provokes nanotoxicity: explanation of oral toxicity of nano-

copper particles. Toxicological. Letter, 175, 102–110.

Huabing Chen, Hongda Zhu, Jingnan Zheng, Dongsheng Mou , Jiangling Wan ,

Junyong Zhang (2009). Iontophoresis-driven penetration of nanovesicles through

microneedle-induced skinmicrochannels for enhancing transdermal delivery of

insulin, Journal of Controlled Release, 139, 63–72.

203

Huabing Chen, Xueling Chang, Danrong Du, Jin Li (2006). Microemulsion-based

hydrogel formulation of ibuprofen for topical delivery, International Journal of

Pharmaceutics, 315, 52–58.

Ichikawa E, Kimura M, Mori H, Yamazaki F, Hirano K (2006). Apparent increase of

insulin peak area in HPLC analysis of a preparation consisting of a mixture of insulin

and total parenteral nutrition, Chemical Pharmacy Bulletin, 54, 1196-1199.

Irfan Newaz Khan, Maria Islam Khan, Kishor Mazumder, Marzina Ajrin (2012).

Characterization and ex-vivo skin permeation study of domperidone maleate

transdermal patch, Bulletin of Pharmaceutical Research, 2, 15-21.

Jalehvarshosaz, (2006). Use of hydrophilic natural gums in formulation of sustained

release matrix tablets of Tramadol hydrochloride, AAPS PharmSciTech, 7, 1–7.

Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ (2001). Chitosan

nanoparticles as delivery systems for doxorubicin. Journal of Controlled Release, 73,

255–267.

Janis Ott Joslin (2009). Blood Collection Techniques in Exotic Small Mammals,

Journal of Exotic Pet Medicine, 2, 117–139.

Jia-You Fang , Tsong-Long Hwang,Yen-Ling Huang, Chia-Lang Fang (2006).

Enhancement of the transdermal delivery of catechins by liposomes incorporating

204

anionic surfactants and ethanol, International Journal of Pharmaceutics, 310, 131–

138.

Jia-You Fang, Chia-Lang Fang , Chi-Hsien Liu , Yu-Han Su (2008). Lipid

nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN)

versus nanostructured lipid carriers (NLC), European Journal of Pharmaceutics and

Biopharmaceutics, 70, 633–640.

Jie Liu Tao Gonga, Hualin Fu Changguang Wang , Xiuli Wang (2008). Solid lipid

nanoparticles for pulmonary delivery of insulin, International Journal of

Pharmaceutics, 356, 333–344.

Jie Liu , Ting Weng ,Yajiang Yang , Huibi Xu , Xiangliang Yang (2006).

Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting, Journal of

Controlled Release, 110, 296 – 306.

Jin Woong Kim, Yoon Kyun Hwang, Jang Won Choi, (2012). Synthetic Polymer

Membranes as a Proxy of Skins in Permeation Studies of Biologically Active

Compounds, Macromolecular Research, 20, 379-384.

Jingkun Jiang, Günter Oberdörster,Pratim Biswas (2009). Characterization of size,

surface charge, and agglomeration state of nanoparticle dispersions for toxicological

studies, Journal of Nanoparticle Research,11, 77-89.

205

Joachim Kohn , Adam J. Singer , Bozena Michniak-Kohn (2011). Topical drug

delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in

vivo skin distribution studies, Journal of Controlled Release ,149,159–167.

Jong-sang Park, Woo-kyoung Lee, Jong-yeun Park, Sangho Jung (2005). Preparation

and characterization of biodegradable nanoparticles entrapping immunodominant

peptide conjugated with PEG for oral tolerance induction, Journal of Controlled

Release, 105, 77–88.

Juergen Lademann , Heike Richter , Alexa Teichmann , Nina Otberg (2007).

Nanoparticles – An efficient carrier for drug delivery into the hair follicles, European

Journal of Pharmaceutics and Biopharmaceutics, 66,159–164.

Kai Shi, Fude Cui, Yingwei Yu, Liqiang Zhang, Anjin Tao, Dongmei Cun (2006).

Preparation and characterization of a novel insulin-phospholipid complex, Insulin-

phospholipid complex/Asian Journal of Pharmaceutical Sciences,1,168-174.

Kesavan Bhaskar, Jayaraman Anbu, Velayutham Ravichandiran, Vobalaboina

Venkateswarlu (2009). Lipid nanoparticles for transdermal delivery of flurbiprofen:

formulation, in vitro, ex vivo and in vivo studies.,Lipids Health Dis, 26, 8, 1-6.

Khemariya P, Jain A, Goswami R, Bhargava M (2010). Advances in Novel Drug

Delivery Carriers: Formulation and In Vitro Evaluation of Solid Lipid Nanoparticles

of Nateglinide, International Journal of Pharmaceutical and Applied Sciences, 1,104-

108.

206

Kihara AH, Moriscot AS, Ferreira PJ (2005). Protecting RNA in fixed tissue: An

alternative method for LCM users. J Neurosci Method, 148, 103–107.

Kotyla T ,Kuob F, Moolchandani V ,Wilson T , Nicolosi R (2008) Increased

bioavailability of a transdermal application of a nano-sized emulsion preparation,

International Journal of Pharmaceutics, 347,144–148.

Ksenia Tonyushkina, James H. Nichols (2009). Glucose Meters: A Review of

Technical Challenges to Obtaining Accurate Results, Journal of Diabetes Science

Technology, 3, 971–980.

Lam CW, James JT, McCluskey R, Hunter RL (2004). Pulmonary toxicity of single-

wall carbon nanotubes in mice, 7 and 90 days after intratracheal instillation.

Toxicological Sciences, 77, 126–134.

Le Thi Mai Ho, Nguyen Tai Chi, Nguyen Minh Triet, Le Ngoc Thanh Nhan (2009).

Preparation of drug nanoparticles by emulsion evaporation method, Journal of

Physics: Conference Series, 187, 12-17.

Lequin R (2005). Enzyme immunoassay (EIA) enzyme-linked immunosorbent assay

(ELISA), Clinical Chemestry, 51, 2415–2428.

207

Lian-Yan Wang , Yong-Hong Gub, Zhi-Guo Su, Guang-Hui Ma (2006). Preparation

and improvement of release behavior of chitosan microspheres containing insulin,

International Journal of Pharmaceuticsm, 311, 187–195.

Lian-YanWang, Yu-xiaWang, Zhi-Guo Su, Guang-Hui M (2008), Uniform-sized

PLA nanoparticles: Preparation by premix membrane emulsification, International

Journal of Pharmaceutics, 359, 294–297.

Lifeng Qi, Zirong Xu, Xia Jiang, Caihong Hu and Xiangfei Zou (2004). Preparation

and antibacterial activity of chitosan nanoparticles, Carbohydrate Research,

339,2693–2700.

Loan Honeywell-Nguyen, Joke A. Bouwstra (2005). Vesicles as a tool for transdermal

and dermal delivery, drug discovery Discovery Today technologiesologies, 1, 67-74.

Lombardi Borgia (2005). Lipid nanoparticles for skin penetration enhancement -

correlation to drug localization within the particle matrix as determined by

fluorescence and paraelectric spectroscopy, Journal of Controlled Release, 110 , 1-9.

Mahesh N. Padamwar, Varsha B. Pokharkar (2006). Development of vitamin loaded

topical liposomal formulation using factorial design approach: Drug deposition and

stability, International Journal of Pharmaceutics, 320,37–44.

208

Mahmoud Abu Abeeleh (2009). Induction of Diabetes Mellitus in Rats Using

Intraperitoneal Streptozotocin: A Comparison between 2 Strains of Rats, European

Journal of Scientific Research, 32, 398-402.

Malay K. Das, Saroj K. Ghosal (2008). Ex vivo and in vivo evaluation of transdermal

Maltesen, Bjerregaard S, Hovgaard L, Havelund S (2009). Analysis of insulin

allostery in solution and solid state with FTIR, Journal of pharmaceutical science, 98,

3265-3277.

Mamot C, Drummond DC, Hong K (2003). Liposome-based approaches to overcome

anticancer drug resistance. Drug Resist Update, 6:271–279.

Manish mishra, hemant kumar, r. k. singha, kamLakar tripathi (2008). diabetes and

nanomaterials, digest journal of nanomaterials and biostructures, 3,109 – 113.

Mansour Mansouri, Hamid Reza Pouretedal, Vida Vosoughi (2011). Preparation and

Characterization of Ibuprofen Nanoparticles by using Solvent/ Antisolvent

Precipitation, The Open Conference Proceedings Journal, 2, 88-94.

Manuela Martins-Green, Annelise E. Barron, Ronald J. Neufeld (2010). Sustained

prolonged topical delivery of bioactive human insulin for potential treatment of

cutaneous wounds, International Journal of Pharmaceutics, 398, 146–154.

209

Mao H, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW

(2001). Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and

transfection efficiency, Journal Control Release, 70, 399–421.

Mao S, Bakowsky U, Kissel T (2006). Self assembled polyelectrolyte nanocomplexes

between chitosan derivatives and insulin. Journal Pharmacy Science, 95, 1035–1048.

Martin j. king, ildiko badea, Jason Solomon (2002). Transdermal delivery of insulin

from a novel Biphasic lipid system in diabetic rats, diabetes technology &

therapeutics, 4,479-488.

Martin SG, Murray JC (2007).Gene-transfer systems for human endothelial cells. Adv

Drug Med Microbiol, 25, 364–368.

Masotti, Marino F, Ortaggi G, Cleofe Palocci (2007). Fluorescence and Scanning

Electron Microscopy of Chitosan/DNA Nanoparticles for Biological Applications,

Modern Research and Educational Topics in Microscopy, 43, 690-700.

Megumu higaki, Mieko kameyama, Masae udagawa, Yukio ueno, Yoko yamaguchi,

Rie igarashi (2006). Transdermal delivery of caco3-nanoparticles containing insulin,

diabetes technology & therapeutics, 8, 369-374.

Mei, Z., et al. (2003) Solid lipid nanoparticle and microemulsion for topical delivery

of triptolide, European Journal of Pharmaceutics and Biopharmaceutics, 56, 189-196.

210

Michelangelo Iannone, Donato Cosco, Felisa Cilurzo, Christian Celia (2008). A novel

animal model to evaluate the ability of a drug delivery system to promote the passage

through the BBB, Neuroscience Letters, 23, 12-19.

Ming-Guang Li, Wan-Liang Lua, Jian-Cheng Wang , Xuan Zhang (2007).

Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut

of rats, International Journal of Pharmaceutics, 329,182–191.

Miyazaki S, Takahashi T, Kubo W, Bachynsky J, Lobenberg R (2003). Poly

butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release

and in vivo skin penetration. Journal of Pharmacy and Pharmaceutical Sciences, 6,

240–245.

Miyazaki, S. (2006) Nanoparticles as carriers for enhanced skin penetration, in E. W.

Smith and H. I. Maibach, eds., Percutaneous Penetration Enhancers: Boca Raton, FL,

CRC Press, 117-124.

Mohammad Reza Avadi, Assal Mir Mohammad Sadeghi, Nasser Mohammad pour,

Saideh Abedin (2010). Preparation and characterization of insulin nanoparticles using

chitosan and Arabic gum with ionic gelation method, Nanomedicine:

Nanotechnology, Biology, and Medicine, 6, 58–63.

Monika Schäfer-Korting, Wolfgang Mehnert , Hans-Christian Korting (2007). Lipid

nanoparticles for improved topical application of drugs for skin diseases, Advanced

Drug Delivery Reviews, 59, 427–443.

211

Morrow, McCarron, woolfson (2007). Innovative strategies for enhancing topical and

transdermal drug delivery, the open drug delivery journal, 1, 36-59.

Mu L, Feng SS (2003). A novel controlled release formulation for the anticancer drug

paclitaxel (Taxol(R)): PLGA nanoparticles containing vitamin E TPGS, Journal of

Controlled Release, 86 (1): 33-48.

Mukesh ,Smita Sharma (2011). Stability Indicating RP-HPLC Method for

Determination and Validation of Repaglinide in Pharmaceutical Dosage Form,

International Journal of ChemTech Research, 3, 210-216.

Müller RH (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers

(NLC) in cosmetic and dermatological preparations, Advanced Drug Delivery

Reviews, 54, 131-155.

Muller RH, Jacobs C, Kayser O (2001). Nanosuspensions as particulate drug

formulations in therapy: rationale for development and what we can expect for the

future. Advance Drug Delivery Review, 47, 3–19.

Muller RH, Keck CM (2004). Challenges and solutions for the delivery of biotech

drugs—a review of drug nanocrystal technology and lipid nanoparticles. Journal of

Biotechnology 113, 151–170.

212

Muller RH, M¨ader K, Gohla S (2000). Solid lipid nanoparticles (SLN) for controlled

drug delivery—a review of the state of the art. Eur. J. Pharm. Biopharmacy, 50, 161–

177.

Muller-Goymann CC (2004). Physicochemical characterization of colloidal drug

delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles

for topical administration, European Journal of Pharmaceutics and Biopharmaceutics,

58, 343–356.

Mustafa M.A. Elsayed , Ossama Y. Abdallah,Viviane F. Naggar, Nawal M.

Khalafallah (2007). Lipid vesicles for skin delivery of drugs: Reviewing three decades

of research, International Journal of Pharmaceutics, 332, 1–16.

Nathan DM, cleary PA, backlund JY (2005). Intensive blood-glucose control with

sulphonylureas or insulin compared with conventional treatment and risk of

complications in patients with type 2 diabetes, lancet, 352, 837-853.

Nicholas A. Peppasa, Nikhil J. Kavimandan (2006). Nanoscale analysis of protein and

peptide absorption:Insulin absorption using complexation and pH-sensitive hydrogels

as delivery vehicles, European journal of pharmaceutical sciences, 2 9, 183–197.

Nidal Qinna , Asim Farouk , Adnan Badwan (2009). Formulation and characterization

of an oily-based system for oral delivery of insulin, European Journal of

Pharmaceutics and Biopharmaceutics, 73,269–279.

213

Nidhin,Indumathy,Sreeram, Balachandran unni nair (2008). Synthesis of iron oxide

nanoparticles of narrow size distribution on polysaccharide templates, bullaten

material science, 31, 93–96.

Olorunfemi, Eseyin, Patrick Ebong, Eyong U (2010). Comparative Hypoglycaemic

Effects Of Ethanolic And Aqueous Extracts Of The Leaf And Seed Of Telfairia

Occidentalis, Turky Journal of Pharmaceutical Science, 7, 29-34.

Omathanu Pillai, Ramesh Panchagnula (2003), Transdermal delivery of insulin from

poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis

and chemical enhancers, Journal of Controlled Release, 89, 127–140.

Orba Y, Tanaka S, Nishihara H (2003), Application of laser capture microdissection

to cytologic specimens for the detection of immunoglobulin heavy chain gene

rearrangement in patients with malignant lymphoma. Cancer, 99, 198–204.

Panagiotis D. Katsoulos, Anastasios Minas, Maria A. Karatzia (2011). Evaluation of

a portable glucose meter for use in cattle and sheep, Veterinary Clinical Pathology,

40, 245–247.

Pandya Narendra, Patel Manvi, Bhaskar, Patel (2011). Development of Transdermal

Drug Delivery System of a Model Antidiabetic Agent, Journal of pharmaceutical

science and biology, 1, 59-64.

214

Patel DV, McGhee CN (2004). Contemporary in vivo confocal microscopy of the

living human pathways of clathrin- and caveolae-mediated endocytosis. Biochem

Journal, 377,159–169.

Patel1 J K, Jivani N P (2009). Chitosan Based Nanoparticles in Drug Delivery,

International Journal of Pharmaceutical Sciences and Nanotechnolog,y 2, 2, 517-522.

Patrícia Severino, Tatiana Andreani, Ana Sofia Macedo, Joana F (2012). Current

State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug

Delivery, Journal of Drug Delivery, 2012, 1-10.

Pavan Kumar, Radhika, Sivakumar (2010). Ethosomes-A Priority in Transdermal

Drug Delivery, International Journal of Advances in Pharmaceutical Sciences, 1,

111-121.

Perez C, Castellanos IJ, Costantino HR (2002). Recent trends in stabilizing protein

structure upon encapsulation and release from biodegradable polymers. J. Pharma

Pharmacology, 54, 301–313.

Pharmacokinetic advances: New formulations of application on the skin and oral

mucosa, Recent Advances in Pharmaceutical Sciences, 37,175-198.

Piao F, Yokoyama K, Ma N, Yamauchi T (2003). Sub acute toxic effects of zinc on

various tissues and organs of rats. Toxicological. Letter, 145, 28–35.

215

Pignatello, Bucolo C, Spedalieri G (2002). Flurbiprofen-loaded acrylate polymer

nanosuspensions for ophthalmic application, Biomaterials, 23, 3247–3255.

Pillai O, Panchagnula R (2001). Insulin therapies—past, present and future. Drug

Discovery Today, 6, 1056–1061.

Posina Anitha, Sundarapandiyan Ramkanth (2011). Preparation, In-Vitro and In-Vivo

Characterization of Transdermal Patch Containing Glibenclamide and Atenolol: A

Combinational Approach, Pakistan Journal of Pharmaceutical Sciences, 2,155-163.

Prasad R, Anand S, Khar RK, Dinda AK, Koul V (2009). Studies on in vitro and in

vivo transdermal flux enhancement of methotrexate by a combinational approach in

comparison to oral delivery, Drug Delivery Indian Pharmacy, 35, 1281-1292.

Prasanta, Murthy PN, Tripathy NK, Panigrahi R, Behera S (2012). Investigation of

Drug Polymer Compatibility, journal of Webmed Central,5, 1-20.

Priscilla Vanessa Finotelli, Daniel Da Silva, Mauro Sola-Penna, Alexandre Malta

Rossi (2010). Microcapsules of alginate/chitosan containing magnetic nanoparticles

for controlled release of insulin, Colloids and Surfaces B: Biointerfaces, 81, 206–211.

Rabinarayan Parhi, Padilama Suresh (2010). Production of Solid Lipid Nanoparticles-

Drug Loading and Release Mechanism, Journal of Chemical and Pharmaceutical

Research,2,211-227.

216

Rachna Rastogia, Sneh Ananda, Veena Koul (2009). Flexible polymerosomes—An

alternative vehicle for topical delivery, Colloids and Surfaces B: Biointerfaces, 72,

161–166.

Rafael A. Shimkunas , Erik Robinson,Robert Lam, Steven Lu (2009). Nanodiamond–

insulin complexes, as pH-dependent protein delivery vehicles, Biomaterials, 30,

5720–5728.

Reddy KR, Mutalik S, Reddy S (2003). Once daily sustained release matrix tablets of

nicorandil: formulation and invitro evaluation. AAPS PharmSciTech, 4, 61.

Rejman J, Oberle V, Zuhorn IS (2005). Size-dependent internalization of particles via

the Resources,12, 214–218.

Renbo song, Yujie J ding, Yuliya D (2007). Finger printing insulin in the spectral

region from mid-IR, International Journal of High Speed Electronics and Systems, 17,

251-260.

Ricci, M., (2005). Evaluation of indomethacin percutaneous absorption from

nanostructured lipid carriers (NLC): in vitro and in vivo studies, Journal of

Pharmaceutical Sciences, 94, 1149-1159.

Richard Sallie (2005). Implications for immune recognition, viral autoimmunity and

other virus receptor diseases, Virology Journal, 2, 70-78.

217

Roberto Vargas, John T Repke (2010). Type III Diabetes Mellitus and Pregnancy,

Rev Obstet Gynecol, 3, 92–100.

Roberts MS, Cross SE (2011). Dermatological and transdermal formulations: Drugs

and the Pharmaceutical Sciences, New York, Marcel Dekker, 4,89 - 195.

Ruihua Wang, Longnian Li, Bing Wang, Tangde Zhang (2012). FK506-loaded solid

lipid nanoparticles: Preparation, characterization and in vitro transdermal drug

delivery, African Journal of Pharmacy and Pharmacology, 6, 904-913.

Ruixue Yin , Jing Han, Jianfeng Zhang, Jun Nie (2010). Glucose-responsive

composite microparticles based on chitosan, concanavalin A and dextran for insulin

delivery, Colloids and Surfaces B: Biointerfaces, 76, 483–488.

Sadeghi , Dorkoosh , Avadi , Weinhold , Bayat (2008). Permeation enhancer effect

of chitosan and Chitosan derivatives: Comparison of formulations as soluble polymers

and nanoparticulate systems on insulin absorption in Caco-2 cells, European Journal

of Pharmaceutics and Biopharmaceutics, 70, 270–278.

Sanjay K. Motwani , Shruti Chopra, Sushma Talegaonkar, Kanchan Kohli (2008).

Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular

delivery: Formulation, optimisation and in vitro characterization, European Journal of

Pharmaceutics and Biopharmaceutics, 68, 513–525.

218

Santander Ortega MJ, Bastos-González D, Ortega-Vinuesa JL (2009). Insulin-loaded

PLGA nanoparticles for oral administration: an in vitro physico-chemical

characterization, Journal of Biomedical Nanotechnology, 5, 45-53.

Sarathchandiran (2012). Review on nanotechnology in solid lipid

nanoparticles,International journal of pharmaceutical development & technology, 2,

45-61.

Sarker (2005). Engineering of nanoemulsions for drug delivery. Current Drug

Delivery, 2, 297–310.

Schmidts, Dobler C, Nissing F. Runkel (2009). Influence of hydrophilic surfactants

on the properties of multiple W/O/W emulsions, Journal of Colloid and Interface

Science, 338, 184–192.

Senthil Rajan, Veeran Gowda, Mandal, Ganesan (2006). Development of RP-HPLC

for analysis of human insulin, Indian Journal Pharmaceutics Science, 68, 62-69.

Shaoyun Yu, Ying Zhao, Fenglan Wu, Xuan Zhang. (2004). Nasal insulin delivery in

the chitosan solution: in vitro and in vivo studies, International Journal of

Pharmaceutics, 281 11–23.

Sharma, Wilson , van der Walle , Sattar (2010). Microemulsions for oral delivery of

insulin: Design, development and evaluation in streptozotocin induced diabetic rats,

European Journal of Pharmaceutics and Biopharmaceutics, 76,159–169.

219

Shelesh Jain, Swarnlata Saraf (2009). Influence of processing variables and in vitro

characterization of glipizide loaded biodegradable nanoparticles, Diabetes &

Metabolic Syndrome: Clinical Research & Reviews, 3,113–117.

Sheree E, Cross Brian Innes, Michael S, Roberts, Takuya Tsuzuki (2007). Human

Skin Penetration of SunscreenNanoparticles: In-vitro Assessment of a Novel

Micronized Zinc Oxide Formulation, Skin Pharmacology & Physiology, 20,148–154,

Shim (2004). Transdermal delivery of minoxidil with block copolymer nanoparticles,

Journal of Controlled Release, 97, 477-484.

Simeonova M, Velichkova R , Ivanovab G, Enchev V (2003).

Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil,

International Journal of Pharmaceutics, 263,133–140.

Sion A. Coulmana, Alexander Ansteyb, Chris Gateleyb, Anthony Morrissey (2009).

Microneedle mediated delivery of nanoparticles into human skin, International

Journal of Pharmaceutics, 366,190–200.

Soma CE, Dubernet C, Bentolila D (2000). Reversion of multidrug resistance by

coencapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate

nanoparticles. Biomaterials, 21,1–7.

220

Soni S, Babbar AK, Sharma RK (2005). Delivery of hydrophobised 5-fluorouracil

derivative to brain tissue through intravenous route using surface modified nanogel. J

Drug Target, 14, 87–95.

Souto E B (2004). Development of a controlled release formulation based on SLN and

NLC for topical clotrimazole delivery, International Journal of Pharmaceutics, 27, 71-

77.

Srinivas Mutalik, Nayanabhirama Udupa (2005). Formulation development, in vitro

and in vivo evaluation of membrane controlled transdermal systems of glibenclamide,

Journal of Pharmaceutical Science, 8, 26-38.

Srinivas, Ramana Murthy (2010). Preparation and evaluation of polyelectrolyte

complexes for oral controlled drug delivery, Asian journal of pharmaceutical

sciences.13, 69-78.

Strage, Lilliehöök (2010). Comparison of feline insulin results when analyzed with

feline, equine and human insulin ELISA test, ECVIM-C, 23, 56-70.

Subash, Pillai ,Senthil Kumar, Panneerselvam (2011). Effect of polymeric activity on

transdermal patches of Glipizide, Research in Pharmacy, 1, 1-5.

Sunil A. Agnihotri, Nadagouda N. Mallikarjuna, Tejraj M. Aminabhavi (2004).

Recent advances on chitosan-based micro- and nanoparticles in drug delivery, Journal

of Controlled Release, 100, 5 –28.

221

Sunil K. Jain , Awasthi , Jain ,Agrawal (2005). Calcium silicate based microspheres

of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro

characterization, Journal of Controlled Release, 107,300– 309.

Suvakanta dash, Padala narasimha murthy, Lilakanta nath (2010). Kinetic modeling

on drug release from controlled drug delivery systems, acta poloniae pharmaceutical

drug research, 67, 217-223.

Taner Şenyiğit, Fabio Sonvico , Stefano Barbieri , Özgen Özer (2004).

Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation

in pig skin, Journal of Controlled Release, 142, 368–373.

Tarl W. Prow , Jeffrey E. Grice , Lynlee L. Lin , Rokhaya Faye (2011). Margaret

Butler c, Wolfgang Becker, Nanoparticles and microparti,Advanced Drug Delivery

Reviews, 7, 17-27.

Thanou M, Verhoef JC, Junginger HE (2001). Chitosan and its derivatives as

intestinal absorption enhancers. Advance Drug Delivery. Review, 50, 91–101.

Tin W. Wong (2009). Chitosan and Its Use in Design of Insulin Delivery System,

Recent Patents on Drug Delivery & Formulation, 3, 8-25.

Torchilin VP (2006). Multifunctional nanocarriers. Advanced Drug Delivery Review,

58,1532–1555.

222

Tung Si Ho, Trine Grønhaug Halvorsen, Stig Pedersen-Bjergaard (2003). Liquid

phase microextraction of hydrophilic drugs by carrier-mediated transport, Journal of

Chromatography A, 998, 61–72.

Valenzano KJ, Miller W, Kravitz JN (2000). Development of a fluorescent ligand-

binding assay using the AcroWellTM filter Plate. J Biomol Screening, 5, 455–461.

Van der Walle C F, Sattar N, Petrie J R, Ravi Kumar M N V (2010). Microemulsions

for oral delivery of insulin:Design, development and evaluation in streptozotocin

induced diabetic rats, European Journal of Pharmaceutics and Biopharmaceutics, 76

159–169.

Vauthier, C (2003). Poly(alkylcyanoacrylates) as biodegradable materials for

biomedical applications, Advanced Drug Delivery Reviews, 55, 519-548

Victor Frenkel, Eitan Kimmel , Yoni Iger (2000). Ultrasound-facilitated transport of

silver chloride (AgCl) particles in fish skin, Journal of Controlled Release, 68,251–

261.

Vikas dash, Sujeet k mishra , Manoj singh (2009). Release Kinetic Studies of Aspirin

Microcapsules from Ethyl Cellulose, Cellulose Acetate Phthalate and their Mixtures

by Emulsion Solvent Evaporation Method, Scintica Pharmaceutical, 78, 93–101.

223

Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ (2002). Design of biodegradable

particles for protein delivery. J. Controlled Release, 78, 15–24.

Vivek Kumar Gupta, Karar, Ramesh, Misra, Alok Gupta (2010). Nanoparticle

Formulation for Hydrophilic & Hydrophobic Drugs, Int. J. Research Pharmaceutical

Sciences, 2,163-169.

Vjera Grabovac, Florian F¨oger, Andreas Bernkop-Schn¨urch (2008). Design and in

vivo evaluation of a patch delivery system for insulin based on thiolated polymers,

International Journal of Pharmaceutics. 34, 169–174.

Vuppugalla R, Agarwal V, Khan M (2003). A simple HPLC method for the

simultaneous analysis of insulin and ovomucoid, Pharmazie, 58, 793-805.

Vyom Sharma, Ritesh K. Shukla, Neha Saxena (2009). DNA damaging potential of

zinc oxide nanoparticles in human epidermal cells, Toxicology Letters, 12, 97–112.

Wahman, Boushra M, El-Houssieny, Lobna F (2010) Bioavailability and biological

activity of liquisolid compact formula of Repaglinide and its effect on glucose

tolerance in rabbits, BioScience Trends, 4,17-24.

Wang Chun, Fu Xiong, Yang LianSheng (2007). Water-soluble chitosan

nanoparticles as a novel carrier system for protein delivery, Chinese Science

Bulletin,52, 883-889.

224

Wang F, Chen, Benson Y H A E (2008). Formulation of Nano and Micro PLGA

Particles of the Model Peptide Insulin: Preparation, Characterization, Stability and

Deposition in Human Skin, The Open Drug Delivery Journal, 2, 1-9.

Waree Tiyaboonchai (2003). Chitosan Nanoparticles : A Promising System for Drug

Delivery, Naresuan University Journal, 11, 51-66.

Waree Tiyaboonchai , James Woiszwillo , Robert C. Sims (2003). Insulin containing

polyethylenimine–dextran sulfate nanoparticles, International Journal of

Pharmaceutics, 255, 139–151.

Wenfeng Jiang, Chunhong Ren, Jianshu Li , Jianyu Xin (2010). Effective protection

and controlled release of insulin by cationic β-cyclodextrin polymers from

alginate/chitosan nanoparticles, International Journal of Pharmaceutics, 393, 212–218.

William (2001). Optimizing Glycemic Control:The Search for Feasible Noninvasive

Insulin Delivery Systems, canadian journal of diabetes, 27,42-51.

Wilson PJ, Basit AW (2005). Exploiting gastrointestinal bacteria to target drugs to the

colon: an in vitro study using amylase coated tablets. International Journal Pharmacy,

300, 89–94.

Wolfgang Mehnert, Karsten Ma¨der (2001). Solid lipid nanoparticles Production,

characterization and applicationsAdvanced Drug Delivery Reviews, 47, 165–196,

225

Xiang Yuan Xiong , Yu Ping Li , Zi Ling Li, Chun Li Zhou (2007). Vesicles from

Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery,

Journal of Controlled Release, 120,11–17.

Xuan Huang , Yong-Zhong Dub, Hong Yuan , Fu-Qiang Hu (2009). Preparation and

pharmacodynamics of low-molecular-weight Chitosan nanoparticles containing

insulin, Carbohydrate Polymers, 76,368–373.

Xuan Zhang,Wanliang Lü, Hua Zhang, Qiang Zhang (2004). Nasal insulin delivery in

the chitosan solution: in vitro and in vivo studies, International Journal of

Pharmaceutics, 281, 11–23.

Xue-Qing Wang , Ai-Ping Zheng , Qiang Zhang(2007) . Distribution, transition,

adhesion and release of insulin loaded nanoparticles in the gut of rats, International

Journal of Pharmaceutics, 329,182–191.

Yamamoto S, Kobashi S, Tsutsui KI,Yoshimi S (2007). Spectroscopic studies of the

interaction between methylene blue–naphthol orange complex and anionic and

cationic surfactants. Spectrochemistry Acta A, 66, 302–306.

Yan Chen, Vellore J. Mohanraj, Fang Wang, Heather A.E. Benson (2007). Designing

Chitosan–Dextran Sulfate Nanoparticles Using Charge Ratios, AAPS PharmSciTech,

8,1-9.

226

Yanjun Zhao, Slobodanka Tamburic, Stuart A. Jones (2010). The role of vehicle–

nanoparticle interactions in topical drug delivery, International Journal of

Pharmaceutics, 400, 176–182.

Yasmin Begum, Abbulu, Sudhakar, Jayaprakash (2011). Studies on the development

of Celecoxib transdermal patches, International Journal of PharmTech Research,3,

1609-1615.

Ying-zhe li, ying-shu quan, lei zang, mei-na jin, fumio kamiyama hidemasa katsum

(2008). Transdermal delivery of insulin using trypsin as a biochemical enhancer, biol.

Pharmacy bulletin, 31, 1574—1579.

Zengshuan Ma , Tit Meng Lim , Lee-Yong Lim( 2005). Pharmacological activity of

peroral chitosan–insulin nanoparticles in diabetic rats, International Journal of

Pharmaceutics, 293, 271–280.

Zengshuan ma, Hock hin yeoh, Lee-yong lim (2007). Formulation pH Modulates the

Interaction of Insulin with Chitosan Nanoparticles, Journal of pharmaceutical

sciences, 6, 12-19.

Zhao X, Zu Y, Zu S, Wang D, Zhang Y, Zu B (2010). Insulin nanoparticles for

transdermal delivery: preparation and physicochemical characterization and in vitro

evaluation, Drug Delivery of Indian Pharmacy, 36, 1177-1185.